Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_assertion type Assertion NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_head.
- NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_provenance.
- NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_assertion evidence source_evidence_literature NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_provenance.
- NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_assertion SIO_000772 7539775 NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_provenance.
- NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_assertion wasDerivedFrom befree-20140225 NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_provenance.
- NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_assertion wasGeneratedBy ECO_0000203 NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_provenance.